OSU molecular geneticist wins NSF award for most promising young scientists

Ohio State Universty Assistant Professor of Molecular Genetics Keith Slotkin has received the National Science Foundation’s highest award for the country’s most promising young scientists, the NSF CAREER Award.

These grants are given to researchers who early in their careers have clearly demonstrated their potential for making significant discoveries in their fields. Slotkin studies transposable elements, sometimes called “jumping genes,” that are stretches of DNA that can duplicate or move from one location in the genome to another.

“These are fragments of DNA that reside in the genomes of multicellular organisms,” Slotkin said. “They’re not considered actual genes, but they’re like little genomic parasites. They are out only to duplicate themselves—not to help the organism they reside in.”

Their highly-successful ability to do just that has resulted in transposable elements occupying vast amounts of most plant and animal genomes. “For example, they occupy nearly half of the human genome, and 85% of corn,” Slotkin said.

Although often overlooked or dismissed as “junk DNA,” transposable elements have played an important role in the structure and evolution of these genomes.

One of the key questions is why transposable elements have been conserved through time.

“Maybe,” Slotkin said, “they have a key function in the organism. But we don’t yet know whether they are pure parasites or have another function.

“But we do know that when transposable elements are active—that is when they ‘jump,’ they cause damage, which includes chromosome breakage, instability, and disease and can destroy an organism very quickly from inside.”

Recent Posts

Blog Post Archive

Blog Post Categories

Search the Blog

Newsticker


BioOhio Member Mark BioOhio Member

STERIS Corporation buys U.S. Pipe building to expand in Birmingham, AL | WBRC6 Birmingham AL, August 20, 2014

Case Western Reserve University hosts cancer stem cell conference | WKSU Kent University, August 20, 2014

Sinus infection test invented by Ohio State University and Nationwide Children’s Hospital could curb antibiotic overuse | Columbus Business First, August 20, 2014

HealthSpot and CareSource team to improve access to healthcare | BusinessWire, August 20, 2014

EnvisionRxOptions named to Inc. Magazine’s The Inc. 500|5000″ list of America’s fastest-growing companies for second consecutive year | Herald Online, August 20, 2014

Forty attorneys from member firm McNees Wallace & Nurick recognized as Best Lawyers in America | McNees Wallace & Nurick, August 19, 2014

Minimally Invasive Devices and Mitsubishi Medical Japan forge exclusive distribution agreement | PR Newswire, August 19, 2014

Summa Health System President and CEO Thomas Strauss will retire at end of 2014 | Crains Cleveland, August 19, 2014

New device at Ohio State Wexner Medical Center takes aim at cluster headaches | WBNS 10TV Columbus, August 18, 2014

BioOhio Blog: OffWhite reflects on the BioOhio Expo, education is the best kind of marketing | BioOhio, August 15, 2014

$2.71M allocated to improve colleges and universities around Ohio | Cleveland.com, August 15, 2014

ChanTest announces a global campaign to share new findings and developments in cystic fibrosis research | PR Web, August 14, 2014

Cleveland Clinic cancer center gets thumbs-up from city design review committee | The Plain Dealer, August 14, 2014

Cleveland Clinic Chief of Staff Dr. Joseph Hahn to retire after nearly four decades as a neurosurgeon, leader and innovator | The Plain Dealer, August 14, 2014

Senator Rob Portman visits Assurex Health to learn about tests to help veterans struggling with post-traumatic stress disorders and other mental illnesses | Cincinnati.com, August 13, 2014

Collaboration between Miami Valley Hospital and Dayton Children’s Hospital to provide care for high-risk pregnancies and at-risk newborns | PR Web, August 13, 2014

Bacterial Robotics building bactobots engineered to destroy skull-based tumors | MedCity News, August 12, 2014

Lindsey Burns, Clincial Development Associate at Assurex Health, named a 2014 Professional Woman of the Year by the National Association of Professional Women | PR Web, August 12, 2014

Juventas Therapeutics completes enrollment of Phase I/II RETRO-HF trial and demonstrates safety for retrograde infusion of JVS-100 in patients with heart failure | PR Newswire, August 12, 2014

Trends driving Cincinnati’s health care building boom | Cincinnati.com, August 12, 2014